We are likely to encounter the #COVID19 virus again as we enter another respiratory virus season, and the gravity of your next COVID-19 episode depends on a variety of factors. Here are key things to keep in mind about repeat COVID infections as we approach the fall and winter months: https://lnkd.in/g6WEr76v
Moderna
Biotechnology Research
Cambridge, Massachusetts 613,555 followers
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
About us
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
- Website
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
External link for Moderna
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- Biotechnology and mRNA Therapeutics
Locations
-
Primary
200 Technology Sq
Cambridge, Massachusetts 02139, US
-
1 Upland Rd
Norwood, Massachusetts 02062, US
Employees at Moderna
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX Leader | Critical Design Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
Associate Director, Pharmacovigilance Operations - Project Management (PgMP/PMP)
Updates
-
For Keke Wu, Senior Director of People Analytics at Moderna, her role isn't just about crunching numbers; it's about fostering an environment where every employee can thrive. Learn more about Keke's path to people analytics, and her changemaker journey at Moderna: https://lnkd.in/gAT4W6Px
-
-
We announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorized our updated COVID-19 vaccine targeting the JN.1 variant of SARS-CoV-2. Following the MHRA decision, doses will be available for eligible groups as part of the NHS autumn vaccination program, which is prioritized for use in people at greatest risk of serious illness from COVID-19. Read more: https://lnkd.in/eNuqyJpJ
-
-
Economists estimate that #LongCOVID has forced around one million Americans out of the labor force, and it is most prevalent among Americans in their prime working years. Studies show that COVID vaccines reduce the risk of Long COVID by up to 70% — underscoring the importance of CDC’s recommendation to stay up to date with COVID vaccinations. Learn more about this public health crisis: https://lnkd.in/eFc_aqYg
Long Covid Knocked a Million Americans Off Their Career Paths
wsj.com
-
Vaccines play a vital role in public health. Data from the World Health Organization show that vaccines prevent an estimated 3.5 to 5 million deaths each year from 20 different diseases. This National Immunization Awareness Month, read more about the vaccines you need to protect yourself this fall, and how you can help protect yourself and your community from some of the most common respiratory illnesses this winter ⬇ https://lnkd.in/eKEnC_Bd
-
-
We’re excited to announce the launch of our new awareness campaign, “Do It For You & Them.” This initiative is part of our broader efforts to educate the public about the ongoing risks of COVID-19 and its continued impact on daily life. With COVID-19 infection rates still elevated across the country, staying up to date on your COVID-19 vaccination is one of the best ways to protect yourself and your loved ones. Updated vaccines are now available — find one near you today: ForYouAndThem.com
-
COVID-19 remains a significant health risk and is the leading cause of respiratory illness-related hospitalization. According to the CDC, people over 65 are at least three times more likely to be hospitalized due to #COVID19 than the #flu, and at least seven times more likely than #RSV. Staying up to date on your COVID-19 vaccination is one of the best ways to protect yourself and your loved ones. Updated vaccines are now available —find one near you today: ForYouAndThem.com
-
-
We believe that education is key to lifting people out of poverty and creating a more equitable future, and we are committed to reducing socioeconomic inequalities in #STEM education for women. Through our Foundation, we’re investing in organizations like Science Club for Girls, who makes STEM accessible and exciting for girls and gender-expansive youth from underrepresented communities. By providing free, hands-on STEM programs and connecting youth with women-in-STEM mentors, these initiatives are not just teaching science — they're fostering confidence, resilience, and a lifelong love of learning. Together, we’re building a fully inclusive and innovative ecosystem where everybody has the opportunity to succeed in STEM. #WomensEqualityDay
-
-
We announced today that the European Commission has granted marketing authorization for our mRNA respiratory syncytial virus (RSV) vaccine. The marketing authorization follows the Positive Opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). Read more: https://lnkd.in/e6rDu_zs
-
-
We announced today that we have received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of our COVID-19 mRNA vaccine targeting the SARS-CoV-2 variant JN.1. Read more: https://lnkd.in/efyRRH4k
-